News & Analysis on Clinical Trial Services & Contract Research And Development
In the UK, a groundbreaking partnership between government and industry has led to the creation of a National Biomanufacturing Centre, designed to make it easier for fledgling biotechnology companies to get access to contract manufacturing for...
UK business has attacked the government for handing out what it claims is a £4 billion annual bill as a result of 'sloppy' environmental laws, report Anthony Fletcher and Phil Taylor.
The market for pharmaceutical fine chemicals will remain static until 2005 and overcapacity will continue to be a problem, predicts Global Pharmaceutical Fine Chemicals - Industry and Market Analysis, a new report from Urch Publishing.
Oxford BiomMedica has entered into a partnership with a US company to try to overcome the primary obstacles to producing recombinant proteins in eggs, the low level of expression of the gene transcript coding for the target protein and difficulties...
Dermatrends, a US drug delivery company, has been awarded a patent that covers the method of using bases to enhance the permeation of amine drugs across the skin and could lead to new products for Alzheimer's and other diseases.
Researchers have demonstrated for the first time that physical symptoms and neurological damage caused by an inherited neurodegenerative disease that is similar to Huntingdon's disease (HD) may be prevented by gene therapy.